Carolyn Myers

Chief Executive Officer at FENDX TECHNOLOGIES INC.

Net worth: 172 372 $ as of 2026-06-29

68 year

80 connections

Health Technology

Process Industries

Consumer Services

Profile

Carolyn J.
Myers is currently President, Chief Executive Officer & Director at FendX Technologies, Inc. since 2020.
Dr. Myers is also a Director at EyeD Pharma SA, Principal at Bio Ensemble Ltd., Committee Member and principal at Mid Atlantic Bio Angels LLC, and Principal at Bioensemble LLC since 2017.
Former roles include Global Director-Cardiovascular at Pharmacia, Inc., Non-Executive Director at Mayne Pharma Group Ltd. from 2021 to 2023, Independent Non-Executive Director at Hyloris Pharmaceuticals SA, Vice President at Mylan Laboratories, Inc. from 2003 to 2007, President at Mylan Specialty LP, President-Specialty Pharmaceutical Division at Mylan, Inc., President at Mylan Technologies, Inc. from 2006 to 2007, President at Dey Laboratories, Inc., Vice President-CNS Marketing at Forest Laboratories, Inc. from 2011 to 2013, and Vice President-Global Business Development at Allergan UC from 2011 to 2017.
Education includes an MBA from Rutgers State University of New Jersey and a doctorate from the University of British Columbia.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
FENDX TECHNOLOGIES, INC. 9.18%	2026-01-18	857,574 ( 9.18% )	172 372 $	2026-06-29

Carolyn Myers active positions

Companies	Position	Start
FENDX TECHNOLOGIES INC.	Chief Executive Officer	2020-07-27
EyeD Pharma SA EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products	Director/Board Member	-
Bio Ensemble Ltd. Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and business strategy consulting services for pharmaceutical and healthcare industry	Corporate Officer/Principal	-
Mid Atlantic Bio Angels Mid Atlantic Bio Angels Investment ManagersFinance Mid Atlantic Bio Angels invests in companies located across the globe. The firm targets companies operating in the field of Life science sectors and industries. It provides financing for early stage capital requirements with an investment size of USD 0.25 - 1 million. It also participates in co-investment and follow-on rounds.	Private Equity Investor	-

All active positions of Carolyn Myers

Former positions of Carolyn Myers

Companies	Position	End
MAYNE PHARMA GROUP LIMITED	Director/Board Member	2023-07-30
ALLERGAN PLC	Corporate Officer/Principal	2017-02-28
FOREST LABORATORIES, INC.	Corporate Officer/Principal	2013-09-30
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets respiratory disease & allergy treatment products	President	2011-06-29
Mylan Laboratories, Inc. Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals	Corporate Officer/Principal	2007-10-01

See the detail of Carolyn Myers's experience

Training of Carolyn Myers

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carolyn Myers's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	16
Forest Laboratories, Inc. Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products	Health Technology
Mylan Laboratories, Inc. Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Develops and manufactures generic pharmaceuticals	Health Technology
Mylan Specialty LP Mylan Specialty LP Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets respiratory disease & allergy treatment products	Health Technology
Mylan, Inc. Mylan, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures generic pharmaceuticals	Health Technology
Mylan Technologies, Inc. Mylan Technologies, Inc. Containers/PackagingProcess Industries Manufactures and distributes transdermal products	Process Industries
Rutgers State University of New Jersey Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of British Columbia University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Pharmacia, Inc.
Dey Laboratories, Inc.
Allergan Ltd. (Ireland) Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes pharmaceuticals, devices, biological, surgical & regenerative medicine products	Health Technology
Mayne Pharma Group Ltd. Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products	Health Technology
Bio Ensemble Ltd. Bio Ensemble Ltd. Miscellaneous Commercial ServicesCommercial Services Provides management and business strategy consulting services for pharmaceutical and healthcare industry	Commercial Services
Mid Atlantic Bio Angels Mid Atlantic Bio Angels Investment ManagersFinance Mid Atlantic Bio Angels invests in companies located across the globe. The firm targets companies operating in the field of Life science sectors and industries. It provides financing for early stage capital requirements with an investment size of USD 0.25 - 1 million. It also participates in co-investment and follow-on rounds.	Finance
EyeD Pharma SA EyeD Pharma SA Medical SpecialtiesHealth Technology Manufactures and supplies ophthalmology surgical products	Health Technology
Hyloris Pharmaceuticals SA Hyloris Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products by reformulating well-known drugs	Health Technology
FendX Technologies, Inc. FendX Technologies, Inc. Industrial SpecialtiesProcess Industries Engages in manufacturing, research, development and distribution of surface protection products	Process Industries